Raymond James Financial’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
OIA
WIA
CCMG
Raymond James Financial's BTAL Position: Q3 2025 in Review
Raymond James Financial sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2025, closing a stake of 9,153 shares — an estimated $162K sold.
Raymond James Financial first reported a position in BTAL in Q4 2024 and held it in 2 quarters. The position peaked at $196K in Q4 2024. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2025.
- Raymond James Financial reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2025 after selling out during the quarter.
- Raymond James Financial sold 9,153 AGF US Market Neutral Anti-Beta Fund shares in Q3 2025, an estimated $162K.
- Raymond James Financial first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2024 and held it in 2 quarters.
- Raymond James Financial's AGF US Market Neutral Anti-Beta Fund position peaked at $196K in Q4 2024.
- 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2025.
Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.